Merck Appoints Michael Klobuchar Chief Strategy Officer investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Glen Tullman’s newest healthcare navigation startup, Transcarent, raised another $58 million in funding. The company plans to use the funds to quickly build out its offering for employers.
SFBT Thursday Digest: Facebook s remote work decision; Startups land megarounds bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Transcarent, a San Francisco, CA-based consumer-directed health and care experience for employees of self-insured employers and their families, raised $58m in Series B funding.
The round, which brought total funding to $98m, was led by General Catalyst and 7wireVentures, with participation from Merck Global Health Innovation Fund, Kleiner Perkins, Leaps byBayer, GreatPoint Ventures, and Threshold Ventures along with existing investors Alta Partners and Jove Equity Partners.
The company intends to use the funds to expand its risk-based offering for self-insured employers.
Launched in March 2021 by Glen Tullman, CEO, Transcarent is a health and care experience company that delivers a personalized, 24/7 care experience, addressing virtually all of the most common and most challenging issues a person faces by connecting them with a personal Health Guide or physician, offering expert second opinions, medication review and management, virtual physical therapy, and comprehensive approp